STOCK TITAN

Hydrofarm Q3 2026 sales fall 50.7% to $14.5M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Hydrofarm Holdings Group, Inc. (HYFM) reported third-quarter 2026 net sales of $14.5 million, down 50.7% from $29.4 million a year earlier. Net loss was $7.8 million versus $16.4 million, and Adjusted EBITDA loss was $1.1 million versus $4.4 million.

On July 31, 2026, Hydrofarm sold Aurora Peat Products in Canada for $16 million total consideration, including a $5 million promissory note; proceeds were applied to Term Loan debt and interest. As of September 30, 2026, $109 million of Term Loan principal was outstanding and classified as current debt. The company said its February 4, 2026, election to defer a Term Loan interest payment resulted in an event of default.

In October, the recapitalization eliminated the $109 million Term Loan. Former lenders received $27.5 million of Series 1 Non-Voting Convertible Preferred Stock and warrants to purchase 27.5 million common shares at $0.78 per share. A registered direct offering and concurrent private placement raised approximately $8.3 million in gross proceeds; Hydrofarm expects approximately 41.8 million common shares outstanding following the offering and preferred-stock conversion. Cash used in operating activities was $7.5 million in the quarter. Management expects to transition to positive Adjusted EBITDA in the next year.

4 points · 2 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Major pointOctober recapitalization eliminated $109 million of Term Loan debt. 33× market cap
  • Major pointAurora sale had $16 million total consideration; proceeds reduced Term Loan debt and interest. 4.9× market cap
  • Moderate pointNet loss narrowed to $7.8 million from $16.4 million in Q3 2025.
  • Moderate pointAdjusted EBITDA loss narrowed to $1.1 million from $4.4 million.

Negative

  • Major point$109 million of Term Loan debt was current following an interest-payment default. 33× market cap
  • Moderate pointNet sales fell 50.7% to $14.5 million in Q3 2026.
  • Moderate pointFree cash flow was $(7.5) million, versus $(207,000) in Q3 2025.

Filing Explained

At September 30, 2026, before October’s recapitalization, Hydrofarm reported $3.9 million in cash and restricted cash; this is a quarter-end balance, not a post-recapitalization cash figure.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Net sales $14.5 million Three months ended September 30, 2026; down 50.7% from the prior-year period.
Net loss $7.8 million loss Three months ended September 30, 2026; compared with a $16.4 million loss in the prior-year period.
Adjusted EBITDA $1.1 million loss Three months ended September 30, 2026; compared with a $4.4 million loss in the prior-year period.
Term Loan debt eliminated $109 million Eliminated in the October 2026 recapitalization.
Series 1 Non-Voting Convertible Preferred Stock $27.5 million Received by former Term Loan lenders in the October recapitalization; convertible based on a stated value of $1.00 per share.
Warrants 27.5 million common shares at $0.78 per share Issued to former Term Loan lenders in the October recapitalization.
Offering gross proceeds Approximately $8.3 million Registered direct offering and concurrent private placement.
Expected common shares outstanding Approximately 41.8 million shares Expected following the offering and conversion of the Series 1 preferred stock.
Adjusted EBITDA financial
"expects to transition to positive Adjusted EBITDA in the next year"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Free Cash Flow financial
"Free Cash Flow (Non-GAAP)"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
registered direct offering financial
"sold common stock and warrants to investors in a registered direct offering"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Series 1 Non-Voting Convertible Preferred Stock financial
"a newly created class of Series 1 Non-Voting Convertible Preferred Stock"
event of default financial
"resulting in an event of default"
An event of default is a specific breach of a loan or bond agreement—such as missed payments or breaking agreed rules—that gives lenders the legal right to act, for example by demanding immediate repayment, seizing collateral, or accelerating other obligations. For investors, it’s a red flag because it can sharply reduce a company’s ability to operate or raise money, like a car lender repossessing a vehicle after missed payments, and often leads to falling share or bond prices.
Net sales $14.5 million Down 50.7% from $29.4 million in Q3 2025.
Gross profit $2.6 million Compared with $3.4 million in Q3 2025; gross margin was 17.7% versus 11.6%.
Net loss $7.8 million loss Compared with a $16.4 million loss in Q3 2025.
Adjusted EBITDA $1.1 million loss Compared with a $4.4 million loss in Q3 2025.
Guidance

Hydrofarm expects to transition to positive Adjusted EBITDA in the next year.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did HYFM's sales decline in Q3 2026?

Hydrofarm attributed the sales decline to lower volume and mix related to discontinued distributed brands, Canadian business divestitures, and constrained working capital leading up to the recapitalization.

What did former lenders receive in HYFM's October recapitalization?

Former Term Loan lenders received $27.5 million of Series 1 Non-Voting Convertible Preferred Stock, convertible to common stock based on a stated value of $1.00 per share, and warrants to purchase 27.5 million common shares at $0.78 per share.

How many HYFM common shares does the company expect after the offering and preferred-stock conversion?

Hydrofarm expects approximately 41.8 million common shares outstanding following the offering and conversion of the Series 1 Non-Voting Convertible Preferred Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001695295 0001695295 2026-11-16 2026-11-16
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): November 16, 2026
 

 
Hydrofarm Holdings Group, Inc.
(Exact name of registrant as specified in its charter)
 

 
Delaware
 
001-39773
 
81-4895761
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
1510 Main Street
Shoemakersville, PA 19555
 

(Address of Principal Executive
Offices) (Zip Code)
 
 
Registrant’s telephone number, including area code: (707) 765-9990
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
☐         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
 
☐         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
 
☐         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
HYFM
Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02        Results of Operations and Financial Condition.
 
On November 16, 2026, Hydrofarm Holdings Group, Inc. (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
 

 
Item 9.01        Financial Statements and Exhibits.
 
Exhibit
No.
 
Description
 
 
 
99.1
 
Press Release, dated November 16, 2026.
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 

 
SIGNATURES 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Hydrofarm Holdings Group, Inc.
 
 
 
 
Date: November 16, 2026
By:
/s/ William Toler
 
 
Name:
William Toler
 
 
Title:
Chief Executive Officer & Chairman of the Board of Directors
 
 
 
(Principal Executive Officer)
 

Exhibit 99.1

 

 

 

logohydroar01.jpg

 

Hydrofarm Announces Third Quarter 2026 Results and Subsequent Elimination of Term Loan 

 

 

Shoemakersville, PA — November 16, 2026 — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded supplies and equipment for controlled environment agriculture ("CEA"), today announced financial results for its third quarter ended September 30, 2026.

 

 Third Quarter Events and Comparison vs. Prior Year Period:

 

•

Net sales decreased to $14.5 million compared to $29.4 million.

 

•

Gross Profit Margin increased to 17.7% of net sales compared to 11.6%.

 

•

Adjusted Gross Profit Margin(1) increased to 23.6% of net sales compared to 18.8%.

 

•

SG&A expense and Adjusted SG&A(1) expense decreased by 51.4% and 54.1%, respectively.

 

•

Net loss decreased to $7.8 million compared to $16.4 million.

 

•

Adjusted EBITDA(1) of $(1.1) million compared to $(4.4) million.

 

•

Cash used in operating activities and Free Cash Flow(1) were each $(7.5) million which included a $4.4 million cash interest payment on the now terminated Term Loan debt facility, and $2.8 million of debt and restructuring related payments; compared to cash used in operating activities and Free Cash Flow(1) of less than $(0.1) million and $(0.2) million, respectively. 

 

(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.

 

Hydrofarm also recently completed the following transactions:

 

          •    Sold Aurora Peat Products in the third quarter of 2026 for $16 million gross proceeds, reducing debt and simplifying operating footprint.

          •    Subsequent to the third quarter, Hydrofarm recapitalized the business, eliminating $109 million of Term Loan debt and raising $8.3 million in 

                 gross proceeds.

 

"In the third quarter, our higher margin proprietary brand sales exceeded two-thirds of total sales and contributed to our highest Adjusted Gross Profit margin percentage since Q3 2024.  We also reduced Adjusted SG&A expense by over 50% compared to last year.  We implemented meaningful cost reductions and grew our logistics services business, realizing our 17th consecutive quarter of year-over-year expense reductions. In July, we sold our Aurora Peat Products business for $16 million, a key strategic step in optimizing our portfolio and reducing our Term Loan debt," said William Toler, Chief Executive Officer of Hydrofarm.  "Then in October, we completed the recapitalization of our Company, eliminated the Term Loan debt facility and raised additional equity for the next chapter of our business.  Backed by a stronger financial foundation, we are well-positioned to invest in sustainable growth as we expect to transition to positive Adjusted EBITDA in the next year."

 


 

Third Quarter 2026 Financial Results

 

Net sales decreased 50.7% to $14.5 million compared to $29.4 million in the prior year period. This was due to a decline in volume/mix related to the discontinuation of certain distributed brands, the Company's business divestitures in Canada, and constrained working capital leading up to the Company's recapitalization transaction.  

 

Gross Profit decreased to $2.6 million, or 17.7% of net sales, compared to $3.4 million, or 11.6% of net sales, in the prior year period. Adjusted Gross Profit (1) decreased to $3.4 million, or 23.6% of net sales, compared to $5.5 million, or 18.8% of net sales, in the prior year period. The decreases in Gross Profit and Adjusted Gross Profit (1) were primarily due to lower net sales. Gross Profit Margin and Adjusted Gross Profit Margin (1) increased primarily due to selling a higher proportion of proprietary brand products, partially offset by higher labor and freight costs as a percentage of net sales.  

 

Selling, general and administrative ("SG&A") expense improved to $8.0 million, compared to $16.4 million in the prior year period, and Adjusted SG&A (1) expense improved to $4.5 million compared to $9.9 million in the prior year period. SG&A declined due to lower amortization expense and the Company's cost-saving initiatives, partially offset by costs associated with the Company's strategic alternatives and debt transactions, certain legal and restructuring expenses. In addition, Adjusted SG&A (1) expenses decreased $5.3 million from the Company's cost-saving initiatives, including a $1.5 million decrease in employee compensation costs, a $1.3 million decrease in facility expenses, and other general and administrative costs.

 

Net loss was $7.8 million, or $(1.61) per diluted share, compared to net loss of $16.4 million, or $(3.51) per diluted share in the prior year period. Net loss decreased primarily due to lower SG&A expense and a $1.5 million gain on the sale of the Company's Aurora Peat Products business in Canada. 

 

Adjusted EBITDA (1) improved to $(1.1) million, compared to $(4.4) million in the prior year period. The improvement was related to Adjusted SG&A (1) expense reductions, partially offset by lower net sales and Adjusted Gross Profit (1).

 

Balance Sheet, Liquidity, and Aurora Peat Products Sale

 

As of September 30, 2026, the Company had $3.9 million in cash and restricted cash, compared to $6.6 million as of June 30, 2026.  Cash used in operating activities was $(7.5) million and the Company invested less than $0.1 million in capital expenditures, yielding $(7.5) million Free Cash Flow (1) during the three months ended September 30, 2026.  During the third quarter, the Company paid $4.4 million in cash interest, in connection with the sale of Aurora Peat Products, and $2.8 million related to its debt and strategic alternatives transactions, and restructuring.   As of September 30, 2026, the Company had $109 million in principal balance on its Term Loan outstanding, $7.5 million in finance leases, and $0.1 million in other debt outstanding.

 

As previously disclosed, on February 4, 2026, the Company elected to defer making the interest payment on its Term Loan, resulting in an event of default.  The Term Loan was classified as current debt on the September 30, 2026 balance sheet.  On July 31, 2026, the Company sold its Aurora Peat Products business in Canada for total consideration of $16 million, a portion of which was represented by a promissory note in the amount of $5 million. The sale proceeds were applied to reduce outstanding Term Loan debt and interest.  The sale represented a key strategic milestone, simplifying Hydrofarm's platform into a leaner and more focused organization, and reducing the capital spend of owning and operating peat harvesting assets.  

 

October 2026 Recapitalization 

 

In October 2026, the Company completed its recapitalization, whereby the $109 million Term Loan was eliminated and the former Term Loan lenders received $27.5 million of a newly created class of Series 1 Non-Voting Convertible Preferred Stock, convertible to common stock based on a stated value of $1.00 per share, and warrants to purchase 27.5 million shares of common stock at an exercise price of $0.78 per share.  In addition, Hydrofarm sold common stock and warrants to investors in a registered direct offering and concurrent private placement, raising approximately $8.3 million in gross proceeds (the “Offering”).  Following the Offering and conversion of the Series 1 Non-Voting Convertible Preferred Stock, the Company expects that it will have approximately 41.8 million common shares outstanding.  After the recapitalization, the Company has enhanced liquidity and flexibility to support its strategic initiatives and capitalize on market opportunities, including expanding the direct commercial sales channel, which currently comprises approximately one-third of its business.  Hydrofarm is committed to its strategic priorities to drive high-quality revenue streams, improve profit margins and strengthen its financial position.

 


 

(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.

 

About Hydrofarm Holdings Group, Inc.

 

Hydrofarm is a leading independent manufacturer and distributor of supplies and equipment for controlled environment agriculture, including plant nutrition, growing media, horticultural lighting and climate control solutions, spanning a portfolio of proprietary and select partner brands. The Company manufactures its proprietary plant nutrition and growing media brands in Eugene, Oregon, and, through its logistics services platform, provides third-party warehousing, fulfillment and distribution services across a wide range of industries. For nearly 50 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed.

 


 

Cautionary Note Regarding Forward-Looking Statements

 

Statements contained in this press release, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, including its return to positive Adjusted EBITDA, the expansion of the direct commercial sales channel, the plans and objectives of the Company’s management, and the Company’s assumptions regarding such performance and plans are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” or other similar words or phrases. Actual results could differ materially from the forward-looking information in this release due to a variety of factors, including, but not limited to:

 

The Company's ability to continue as a going concern; The Company's ability to effect strategic changes to its business including the expansion of the logistics services business and direct commercial sales channel; The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which, in turn, has materially adversely impacted the Company's sales and other results of operations and which may continue to do so in the future; If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional impairment charges and/or inventory and accounts receivable reserves, which could be substantial, and, ultimately, the Company may face liquidity challenges; The Company's ability to resolve claims from unsecured creditors in the ordinary course of business; The Company’s future debt facilities may limit the operation of the Company’s business including restricting its ability to sell products directly to the cannabis industry; Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive; Interruptions in the Company's supply chain could adversely impact expected sales growth and operations; Increased prices and inflation could adversely impact the Company's performance and financial results; Global political and economic conditions including the imposition of potential tariffs could increase the costs of the Company's products and adversely impact the competitiveness of the Company's products and the Company's financial results; The Company may be unable to regain compliance and continue to meet the continued listing standards of Nasdaq; The Company's restructuring activities may increase our expenses and cash expenditures, and may not have the intended cost saving effects; The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; Certain of the Company’s products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company’s products; The market for the Company’s products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers; Compliance with government laws and regulations including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; Damage to the Company’s reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business; If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed; The Company’s operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack; The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company’s business and results of operations. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this release is readily available in the Company’s annual, quarterly and other reports. The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments except as otherwise required by law.

 

Contacts:

Investor Contact

ir@hydrofarm.com

 


 

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except share and per share amounts)

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net sales

 

$

14,455

 

 

$

29,350

 

 

$

66,190

 

 

$

109,129

 

Cost of goods sold

 

 

11,897

 

 

 

25,941

 

 

 

59,161

 

 

 

96,049

 

Gross profit

 

 

2,558

 

 

 

3,409

 

 

 

7,029

 

 

 

13,080

 

Operating expenses:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Selling, general and administrative

 

 

7,955

 

 

 

16,365

 

 

 

28,585

 

 

 

50,368

 

Gain on sale of business

 

 

(1,491

)

 

 

—

 

 

 

(1,491

)

 

 

—

 

Loss from operations

 

 

(3,906

)

 

 

(12,956

)

 

 

(20,065

)

 

 

(37,288

)

Interest expense

 

 

(3,385

)

 

 

(3,331

)

 

 

(12,704

)

 

 

(10,099

)

Other (expense) income, net

 

 

(367

)

 

 

22

 

 

 

(464

)

 

 

(140

)

Loss before tax

 

 

(7,658

)

 

 

(16,265

)

 

 

(33,233

)

 

 

(47,527

)

Income tax (expense) benefit

 

 

(121

)

 

 

(125

)

 

 

212

 

 

 

(109

)

Net loss

 

$

(7,779

)

 

$

(16,390

)

 

$

(33,021

)

 

$

(47,636

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss per share:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic

 

$

(1.61

)

 

$

(3.51

)

 

$

(6.90

)

 

$

(10.26

)

Diluted

 

$

(1.61

)

 

$

(3.51

)

 

$

(6.90

)

 

$

(10.26

)

Weighted-average shares of common stock outstanding:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic

 

 

4,817,377

 

 

 

4,663,422

 

 

 

4,786,133

 

 

 

4,641,522

 

Diluted

 

 

4,817,377

 

 

 

4,663,422

 

 

 

4,786,133

 

 

 

4,641,522

 

 

 


 

Hydrofarm Holdings Group, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(In thousands, except share and per share amounts)

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,421

 

 

$

6,309

 

Restricted cash

 

 

460

 

 

 

—

 

Accounts receivable, net

 

 

7,408

 

 

 

8,186

 

Inventories

 

 

19,080

 

 

 

33,324

 

Prepaid expenses and other current assets

 

 

2,167

 

 

 

3,622

 

Total current assets

 

 

32,536

 

 

 

51,441

 

Property, plant and equipment, net

 

 

12,212

 

 

 

30,334

 

Operating lease right-of-use assets

 

 

27,692

 

 

 

37,765

 

Intangible assets, net

 

 

2,801

 

 

 

2,801

 

Other assets

 

 

821

 

 

 

1,463

 

Total assets

 

$

76,062

 

 

$

123,804

 

Liabilities and stockholders’ deficit

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

10,166

 

 

$

9,752

 

Accrued expenses and other current liabilities

 

 

10,068

 

 

 

7,688

 

Deferred revenue

 

 

727

 

 

 

2,742

 

Current portion of operating lease liabilities

 

 

7,562

 

 

 

7,543

 

Current portion of finance lease liabilities

 

 

471

 

 

 

455

 

Current portion of long-term debt

 

 

108,898

 

 

 

111,853

 

Total current liabilities

 

 

137,892

 

 

 

140,033

 

Long-term operating lease liabilities

 

 

24,728

 

 

 

32,800

 

Long-term finance lease liabilities

 

 

7,021

 

 

 

7,381

 

Long-term debt

 

 

33

 

 

 

50

 

Deferred tax liabilities

 

 

—

 

 

 

2,130

 

Other long-term liabilities

 

 

273

 

 

 

4,706

 

Total liabilities

 

 

169,947

 

 

 

187,100

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Stockholders’ deficit

 

 

 

 

 

 

 

 

Common stock ($0.0001 par value; 300,000,000 shares authorized; 4,819,323 and 4,667,004 shares issued and outstanding at September 30, 2026, and December 31, 2025, respectively)

 

 

—

 

 

 

—

 

Additional paid-in capital

 

 

791,595

 

 

 

791,227

 

Accumulated other comprehensive loss

 

 

(5,208

)

 

 

(7,272

)

Accumulated deficit

 

 

(880,272

)

 

 

(847,251

)

Total stockholders’ deficit

 

 

(93,885

)

 

 

(63,296

)

Total liabilities and stockholders’ deficit

 

$

76,062

 

 

$

123,804

 

 


 

Hydrofarm Holdings Group, Inc.

RECONCILIATION OF NON-GAAP MEASURES

(In thousands, except share and per share amounts) 

(Unaudited)

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Reconciliation of Adjusted Gross Profit:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Gross Profit (GAAP)

 

$

2,558

 

 

$

3,409

 

 

$

7,029

 

 

$

13,080

 

Depreciation, depletion and amortization

 

 

736

 

 

 

1,346

 

 

 

2,673

 

 

 

4,075

 

Restructuring expenses1

 

 

102

 

 

 

753

 

 

 

2,859

 

 

 

4,416

 

Other

 

 

10

 

 

 

—

 

 

 

10

 

 

 

—

 

Adjusted Gross Profit (Non-GAAP)

 

$

3,406

 

 

$

5,508

 

 

$

12,571

 

 

$

21,571

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

As a percent of net sales:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Gross Profit Margin (GAAP)

 

 

17.7

%

 

 

11.6

%

 

 

10.6

%

 

 

12.0

%

Adjusted Gross Profit Margin (Non-GAAP)

 

 

23.6

%

 

 

18.8

%

 

 

19.0

%

 

 

19.8

%

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Reconciliation of Adjusted SG&A:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Selling, general and administrative (GAAP)

 

$

7,955

 

 

$

16,365

 

 

$

28,585

 

 

$

50,368

 

Depreciation, depletion and amortization

 

 

33

 

 

 

5,990

 

 

 

115

 

 

 

17,982

 

Restructuring expenses1

 

 

758

 

 

 

142

 

 

 

3,863

 

 

 

162

 

Other2

 

 

1,243

 

 

 

130

 

 

 

1,325

 

 

 

359

 

Stock-based compensation3

 

 

73

 

 

 

207

 

 

 

389

 

 

 

971

 

Debt transactions and strategic alternatives4

 

 

1,306

 

 

 

10

 

 

 

3,600

 

 

 

225

 

Adjusted SG&A (Non-GAAP)

 

$

4,542

 

 

$

9,886

 

 

$

19,293

 

 

$

30,669

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

As a percent of net sales:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

SG&A (GAAP)

 

 

55.0

%

 

 

55.8

%

 

 

43.2

%

 

 

46.2

%

Adjusted SG&A (Non-GAAP)

 

 

31.4

%

 

 

33.7

%

 

 

29.1

%

 

 

28.1

%

 


 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Reconciliation of Adjusted EBITDA:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss (GAAP)

 

$

(7,779

)

 

$

(16,390

)

 

$

(33,021

)

 

$

(47,636

)

Interest expense

 

 

3,385

 

 

 

3,331

 

 

 

12,704

 

 

 

10,099

 

Income tax expense (benefit)

 

 

121

 

 

 

125

 

 

 

(212

)

 

 

109

 

Depreciation, depletion and amortization

 

 

769

 

 

 

7,336

 

 

 

2,788

 

 

 

22,057

 

Restructuring expenses1

 

 

860

 

 

 

895

 

 

 

6,722

 

 

 

4,578

 

Other2

 

 

1,253

 

 

 

130

 

 

 

1,335

 

 

 

359

 

Stock-based compensation3

 

 

73

 

 

 

207

 

 

 

389

 

 

 

971

 

Debt transactions and strategic alternatives4

 

 

1,306

 

 

 

10

 

 

 

3,600

 

 

 

225

 

Gain on sale of business5

 

 

(1,491

)

 

 

—

 

 

 

(1,491

)

 

 

—

 

Other expense (income), net6

 

 

367

 

 

 

(22

)

 

 

464

 

 

 

140

 

Adjusted EBITDA (Non-GAAP)

 

$

(1,136

)

 

$

(4,378

)

 

$

(6,722

)

 

$

(9,098

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

As a percent of net sales:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss (GAAP)

 

 

(53.8

)%

 

 

(55.8

)%

 

 

(49.9

)%

 

 

(43.7

)%

Adjusted EBITDA (Non-GAAP)

 

 

(7.9

)%

 

 

(14.9

)%

 

 

(10.2

)%

 

 

(8.3

)%

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Reconciliation of Free Cash Flow:

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net cash from (used in) operating activities (GAAP):

 

$

(7,486

)

 

$

(37

)

 

$

(8,193

)

 

$

(10,084

)

Capital expenditures of Property, plant and equipment (GAAP)

 

 

(9

)

 

 

(170

)

 

 

(89

)

 

 

(695

)

Free Cash Flow (Non-GAAP):

 

$

(7,495

)

 

$

(207

)

 

$

(8,282

)

 

$

(10,779

)

 

Notes to GAAP to Non-GAAP reconciliations presented above (Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA, and Free Cash Flow):

 

 

1.

For the three and nine months ended September 30, 2026, non-cash restructuring expenses were primarily associated with the write-down of certain right of use assets which were recorded in selling, general and administrative expenses, and inventory write-downs which were recorded in cost of goods sold. Cash charges were primarily comprised of costs incurred to relocate and terminate certain facilities. For the three and nine months ended September 30, 2025, Restructuring expenses primarily related to non-cash inventory markdowns.

 

 

2.

For the nine months ended September 30, 2026, other charges were primarily comprised of accrued legal charges for certain matters. For the nine months ended September 30, 2025, other charges primarily related to legal costs related to the 1-for-10 reverse stock split effected on February 12, 2025, as well as severance charges.

 

 

3.

Includes stock-based compensation and related employer payroll taxes on stock-based compensation for the periods presented.

 

 

4.

For the three and nine months ended September 30, 2026, debt transactions and strategic alternatives charges include legal and advisory services associated with debt transactions, including the forbearance agreement. For the three and nine months ended September 30, 2025, debt transactions and strategic alternatives charges include consulting, transaction services and legal fees for potential acquisitions, divestitures, or strategic combinations. Such amounts were previously presented in the line item titled “Acquisition and integration expenses.”

 

 

5.

For the three and nine months ended September 30, 2026, gain on sale of business reflects the gain recorded for the sale of our Aurora Peat Products business.

 

 

6.

For the three and nine months ended September 30, 2026 and 2025, other expense (income), net related primarily to foreign currency exchange rate gains and losses and other non-operating income and expenses.

 


 

Non-GAAP Financial Measures

 

We report our financial results in accordance with generally accepted accounting principles in the U.S. (“GAAP”). Management believes that certain non-GAAP financial measures provide investors with additional useful information in evaluating our performance and that excluding certain items that may vary substantially in frequency and magnitude period-to-period from net loss provides useful supplemental measures that assist in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.

 

To supplement our condensed consolidated financial statements which are prepared in accordance with GAAP, we use "Adjusted EBITDA", "Adjusted Gross Profit", "Adjusted SG&A", "Free Cash Flow", "Net Debt", and "Liquidity" which are non-GAAP financial measures. We also present certain of these non-GAAP metrics as a percentage of net sales. Our non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are several limitations related to the use of our non-GAAP financial measures as compared to the closest comparable GAAP measures.

 

We define Adjusted EBITDA (non-GAAP) as net loss (GAAP) excluding interest expense, income taxes, depreciation, depletion and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, impairments, severance, loss on asset disposition, other income/expense, net, gain on sale of business, and other non-cash, unusual and/or infrequent costs (i.e., debt transactions and strategic alternatives), which we do not consider in our evaluation of ongoing operating performance.

 

We define Adjusted EBITDA (non-GAAP) as a percent of net sales as Adjusted EBITDA (as defined above) divided by net sales in the respective period.

 

We define Adjusted Gross Profit (non-GAAP) as Gross Profit (GAAP) excluding depreciation, depletion, and amortization, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs, which we do not consider in our evaluation of ongoing operating performance.

 

We define Adjusted Gross Profit Margin (non-GAAP) as a percent of net sales as Adjusted Gross Profit (as defined above) divided by net sales in the respective period.

 

We define Adjusted SG&A (non-GAAP) as SG&A (GAAP) excluding depreciation, depletion, and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.

 

We define Adjusted SG&A (non-GAAP) as a percent of net sales as Adjusted SG&A (as defined above) divided by net sales in the respective period.

 

We define Free Cash Flow (non-GAAP) as Net cash from (used in) operating activities less capital expenditures for property, plant and equipment. We believe this provides additional insight into the Company's ability to generate cash and maintain liquidity. However, Free Cash Flow does not represent funds available for investment or other discretionary uses since it does not deduct cash used to service our debt or other cash flows from financing activities or investing activities.

 

We define Liquidity as total cash, cash equivalents and restricted cash, if applicable.

 

We define Net Debt as total debt principal outstanding plus finance lease liabilities and other debt, less cash, cash equivalents and restricted cash, if applicable.

 

Filing Exhibits & Attachments

5 documents

Keep reading